Novartis’ targeted combination therapy recommended by NICE to treat childhood brain tumours
Gliomas are the most common type of brain cancer in paediatric patients
Read More
Apr 24, 2024 | News, Regulatory
Gliomas are the most common type of brain cancer in paediatric patients
Read MoreThe deal includes an MRGPRX2 antagonist with the potential to treat multiple mast cell-mediated diseases
Read MoreApr 24, 2024 | News, Regulatory
The factor D inhibitor has been authorised for use alongside the company’s complement C5 inhibitors
Read MoreApr 24, 2024 | News, Regulatory
NMIBC accounts for up to 80% of bladder cancer cases, the tenth most commonly diagnosed cancer globally
Read MoreAD is the most common form of dementia, which affects around 55 million people globally
Read MoreApr 23, 2024 | News, Regulatory
Antimicrobial resistance has been declared by WHO as one of the top ten threats to global health
Read MoreApr 23, 2024 | News, Regulatory
The regulator’s decision marks Bimzelx’s fourth approved indication within the EU
Read MoreApr 23, 2024 | News, Regulatory
Inflammatory bowel disease affects around ten million people worldwide
Read MoreThe company was presented with the award in recognition of its Glucowear device
Read MoreThe agreement gives Ipsen an option to receive exclusive global rights to two candidates
Read MoreApr 22, 2024 | News, Regulatory
More than 4,500 new patients are diagnosed with this form of blood cancer every year in the UK
Read MoreApr 22, 2024 | News, Regulatory
The acute diarrhoeal illness was reported to affect around 473,000 people in 2022
Read MoreAccount Specialist - Respiratory - Kent & Medway
National Field Trainer - Oncology - UK Wide
Integrated Care Specialist - North & West Yorkshire
Hospital Specialist - East Midlands